Translating the WHA resolution in a member state: towards a German programme on 'Destigmatization' for individuals with visible chronic skin diseases

被引:18
作者
Augustin, M. [1 ]
Mrowietz, U. [2 ]
Luck-Sikorski, C. [3 ,4 ]
von Kiedrowski, R. [5 ]
Schlette, S. [6 ]
Radtke, M. A. [1 ]
John, S. M. [7 ]
Zink, A. [8 ]
Suthakharan, N. [1 ]
Sommer, R. [1 ]
Blaga, R.
Breitbart, E.
Gaebel, W.
Grosser, M.
Hilbert, A.
Hillmann, O.
Kunz, H-D
Liebram, C.
Middelmann, D.
Schaefer, I
Schueller, C.
Stroemer, K.
Topp, J.
von Spreckelsen, R.
Weigeldt, U.
Weinberger, N.
Wilsmann-Theis, D.
机构
[1] Univ Med Ctr Hamburg Eppendorf UKE, Inst Hlth Serv Res Dermatol & Nursing IVDP, Hamburg, Germany
[2] Univ Med Ctr Schleswig Holstein, Psoriasis Ctr, Dept Dermatol Venereol & Allergol, Kiel, Germany
[3] SRH Univ Appl Hlth Sci Gera, Gera, Germany
[4] Univ Hosp Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany
[5] Dermatol Practice Selters, Selters, Germany
[6] Profess Assoc German Dermatologists BVDD, Berlin, Germany
[7] Univ Osnabrueck, Dept Dermatol Environm Med Hlth Theory, Inst Interdisciplinary Dermatol Prevent & Rehabil, Osnabruck, Germany
[8] Tech Univ Munich, Dept Dermatol & Allergol, Munich, Germany
关键词
CUMULATIVE LIFE-COURSE; QUALITY-OF-LIFE; COURSE IMPAIRMENT; HEALTH-CARE; PSORIASIS; STIGMATIZATION; PERCEPTION; SEVERITY; STIGMA;
D O I
10.1111/jdv.15682
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Even today, a substantial number of individuals with visible skin diseases still suffer from incomprehension and stigmatization. About 10 million people are affected by such diseases in Germany. The WHO strongly urges member states to take measures against stigmatization in skin diseases. Objectives Objectives are the development of an action programme to raise awareness and address stigmatization. Therefore, conception, development and testing of interventions for the destigmatization of persons with skin diseases in Germany will be carried out. Methods A series of actions addressing decision makers, politicians and the Federal Ministry of Health were initiated, all based on the World Health Assembly (WHA). Argumentation was largely based on data from health services research. Supported by the Federal Ministry of Health, a concept against stigmatization was developed by an expert consortium of researchers, dermatologists and patients. Specific strategies of structured destigmatization between those affected and those not will be developed and scientifically evaluated. Results The activities addressed to politics were - to a large extent - successfully and financially supported by a 3-year programme (2018-2020), designed to develop interventions against stigma. It was funded by the Federal Ministry of Health. The project includes conception and development, intervention and evaluation, data analyses and development of a long-term concept. Conclusions The WHO's call against stigmatization in psoriasis (resolution WHA67.9 and global report on psoriasis 2016) was taken into account and developed into a destigmatization programme supported by the German government and German politicians. This has been achieved by successful collaborations between dermatologists, researchers, patients and policymakers. Next step will be the testing of interventions in situations and surroundings, where stigmatization usually occurs. The data will be used for the implementation of a long-term concept that can be used to continue destigmatization in Germany far beyond the project ' s initial phase.
引用
收藏
页码:2202 / 2208
页数:7
相关论文
共 30 条
[21]   Treatment goals in psoriasis routine care [J].
Radtke, M. A. ;
Reich, K. ;
Spehr, C. ;
Augustin, Matthias .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2015, 307 (05) :445-449
[22]   Stigmatization and psoriasis [J].
Richards, HL ;
Fortune, DG ;
Main, CJ ;
Griffiths, CEM .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (01) :209-211
[23]   Cumulative Life Course Impairment: The Imprint of Psoriasis on the Patient's Life [J].
Rosa, S. ;
Puig, L. ;
Carrascosa, J. M. .
ACTAS DERMO-SIFILIOGRAFICAS, 2014, 105 (02) :128-134
[24]   Dimensions of stigmatization in patients with psoriasis in a 'Questionnaire on Experience with Skin Complaints' [J].
SchmidOtt, G ;
Jaeger, B ;
Kuensebeck, HW ;
Ott, R ;
Lamprecht, F .
DERMATOLOGY, 1996, 193 (04) :304-310
[25]  
Sommer R, 2018, HAUTARZT, V69, P1050, DOI 10.1007/s00105-018-4269-4
[26]   What is psoriasis? - Perception and assessment of psoriasis among the German population [J].
Sommer, Rachel ;
Mrowietz, Ulrich ;
Radtke, Marc Alexander ;
Schaefer, Ines ;
von Kiedrowski, Ralph ;
Stroemer, Klaus ;
Enk, Alexander ;
Maul, Julia-Tatjana ;
Reich, Kristian ;
Zander, Nicole ;
Augustin, Matthias .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 (06) :703-710
[27]   Predictors of perceived stigmatization in patients with psoriasis [J].
van Beugen, S. ;
van Middendorp, H. ;
Ferwerda, M. ;
Smit, J. V. ;
Zeeuwen-Franssen, M. E. J. ;
Kroft, E. B. M. ;
de Jong, E. M. G. J. ;
Donders, A. R. T. ;
van de Kerkhof, P. C. M. ;
Evers, A. W. M. .
BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (03) :687-694
[28]   Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients [J].
Vardy, D ;
Besser, A ;
Amir, M ;
Gesthalter, B ;
Biton, A ;
Buskila, D .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (04) :736-742
[29]   Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course [J].
Warren, R. B. ;
Kleyn, C. E. ;
Gulliver, W. P. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 :1-14
[30]  
Young Melodie, 2005, Dermatol Nurs, V17, P15